KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) EBT (2017 - 2025)

Elanco Animal Health (ELAN) has disclosed EBT for 9 consecutive years, with -$259.0 million as the latest value for Q4 2025.

  • Quarterly EBT fell 407.84% to -$259.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$224.0 million through Dec 2025, down 145.9% year-over-year, with the annual reading at -$224.0 million for FY2025, 145.9% down from the prior year.
  • EBT hit -$259.0 million in Q4 2025 for Elanco Animal Health, down from -$50.0 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $559.0 million in Q3 2024 to a low of -$1.1 billion in Q3 2023.
  • Historically, EBT has averaged -$78.6 million across 5 years, with a median of -$50.5 million in 2024.
  • Biggest five-year swings in EBT: plummeted 2393.18% in 2023 and later surged 400.0% in 2025.
  • Year by year, EBT stood at -$120.0 million in 2021, then grew by 25.83% to -$89.0 million in 2022, then plummeted by 42.7% to -$127.0 million in 2023, then surged by 59.84% to -$51.0 million in 2024, then plummeted by 407.84% to -$259.0 million in 2025.
  • Business Quant data shows EBT for ELAN at -$259.0 million in Q4 2025, -$50.0 million in Q3 2025, and $25.0 million in Q2 2025.